GeoVax Labs, Inc. (GOVX) Stock

Healthcare · Biotechnology · Member of Other US Stocks

GeoVax Labs, Inc. (GOVX) closed at USD 0.24 on 2026-10-14, a change of -98.4 % over the past year, with a market capitalization of USD 2.6M.

GeoVax Labs, Inc. recent closing prices

The most recent trading day is not shown. For full charts and indicators use the analysis page.

GeoVax Labs, Inc. key figures

Previous close

USD 0.24 (2026-10-14)

1-year change

-98.4 %

Market cap

USD 2.6M

Enterprise value

USD -920,490

P/E ratio (trailing)

-0.03

P/E ratio (forward)

-0.30

EPS (trailing)

-8.58

EPS (forward)

-0.86

PEG ratio

n/a

Price to book

1.08

Revenue growth

n/a

Earnings growth

n/a

Dividend per share (trailing)

0.00

Short ratio

0.89

Employees

19

Analyst consensus (third-party)

none

Source: Yahoo Finance via yfinance. Data may be delayed, incomplete or incorrect.

About GeoVax Labs, Inc.

GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms in the United States. It develops GEO-CM04S1, a vaccine candidate that is in Phase 2 clinical trial for the treatment of preventive COVID-19; Gedeptin, a novel patented product/technology for the treatment of solid tumors, and Phase 1/2 clinical trial for the treatment of advanced head and neck squamous cell carcinoma; and GEO-CM02, a pan-coronavirus vaccine. In addition, the company offers GEO-MVA-MUC1, a vaccine candidate, which is in preclinical trial for the treatment of solid tumor cancers; GEO-ZM02, a vaccine candidate, which is in preclinical trial for the treatment of Zika; GEO-EMO1-Z, which is in preclinical trial for the treatment of Ebola Zaire; GEO-EMO1-S, which is in preclinical trial for the treatment of Ebola Sudan; GEO-MM01 treatment for marburg; and GEO-MVA for the treatment of Mpox and small pox. It has collaboration and partnership agreements with the National Institute of Allergy and Infectious Diseases of the National Institutes of Health; and the U.S. Department of Defense. GeoVax Labs, Inc. was incorporated in 1988 and is based in Smyrna, Georgia.

Technical indicators and comparison

Show RSI, MACD, EMA, CCI and ADX for GeoVax Labs, Inc. and compare it with other stocks.